Cholecystokinin in the Regulation of Gastric Acid and Endocrine Pancreatic Secretion in Humans

References

• Hirschowitz B I. Neural and hormonal control of gastric secretion. The gastrointestinal system. Handbook of physiology, S G Schultz. American Physiology Society, Bethesda 1989; III: 127–58
   Google Scholar
• Walsh J H. Gastrointestinal hormones. Physiology of the gastrointestinal tract, L R Johnson. Raven Press, New York 1987; 181–251
   Google Scholar
• Corazziari E, Solomon T E, Grossman M I. Effect of ninety-five percent pure cholecystokinin on gastrin stimulated acid secretion in man and in dog. Gastroenterology 1979; 77: 91–5
   PubMed Web of Science ®Google Scholar
• Soll A, Amirian D, Thomas L, Reedy T, Elashoff J. Gastrin receptors on isolated canine parietal cells. J Clin Invest 1984; 73: 1434–47
   PubMed Web of Science ®Google Scholar
• Soll A, Amirian D, Park J, Elashoff J, Yamada T. Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in short-term culture. Am J Physiol 1985; 248: G-569–73
   Google Scholar
• Bengtsson P, Lundquist G, Nilson G. Inhibition of acid formation and stimulation of somatostatin release by cholecystokinin-related peptides in rabbit gastric glands. J Physiol (Lond) 1989; 419: 767–74
   Google Scholar
• Lloyd K CK, Maxwell V, Kovacs T OG, Miller J, Walsh J H. Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. Gastroenterology 1992; 102: 103–38
   Google Scholar
• Konturek S J, Bilski J, Tasler J, Cieszkowski M. Role of cholecystokinin (CCK) in the inhibition of gastric acid secretion in dogs. J Physiol (Lond) 1992; 451: 477–89
   Google Scholar
• Konturek J, Maczka J, Garlicki A. Cholecystokinin (CCK) is the major inhibitor of gastric acid secretion in men. Gastroenterology 1992; 102: A101
   Google Scholar
• Schmidt W E, Schenk S, Folsch U K, Nustede R, Rovati L C, Creutzfeldt W. Cholecystokinin (CCK) stimulates gastric acid secretion in humans in the presence of CCK-A receptor antagonist. Evidence for a CCK-mediated tonic inhibition of the parietal cell. Gastroenterology 1992; 102: A161
   Google Scholar
• Karlsson S, Ahren B. Cholecystokinin and the regulation of insulin secretion. Scand J Gastroenterol 1992; 27: 161–5
   PubMedGoogle Scholar
• Gabryelewicz A, Kulesza E, Konturek S J. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Scand J Gastroenterol 1990; 25: 731–8
   PubMed Web of Science ®Google Scholar
• Makowec F, Bani M, Cereda R. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Drug Res 1987; 37: 1265–8
   Google Scholar
• Hüdebrand P, Beglinger C, Gyr K. Effects of a cholecystokinin receptor antagonists on intestinal phase of pancreatic and biliary responses in men. J Clin Invest 1990; 85: 640–6
   PubMedGoogle Scholar
• Konturek J W, Konturek S J, Kurek A, Bogdal J, Oleksy J, Rovati L C. CCK receptor antagonism by loxiglumide and gallbladder contractions in response to cholecystokinin, sham-feeding and ordinary feeding in man. Gut 1989; 30: 1136–42
   PubMed Web of Science ®Google Scholar
• Savarino V. Continuous intragastric pH monitoring a real progress in the assessment of antisecretory drugs. Ital J Gastroenterol 1990; 22(Suppl 2)10–23
   Google Scholar
• Konturek S J, Swierczek J, Kwiecien N. Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer. Gut 1981; 22: 1003–10
   PubMed Web of Science ®Google Scholar
• Konturek S J, Popiela T, Slowiaczek M, Bielanski W. Gastric acid and pancreatic polypeptide responses to modified sham-feeding. Effects of truncal and parietal cell vagotomy. Gut 1986; 28: 280–6
   Google Scholar
• Morgan C R, Lazarow A L. Immunoassay of insulin: two antibody system. Diabetes 1963; 12: 115–26
   Web of Science ®Google Scholar
• Kokot F, Kuska J. Method of radioimmunoassay of insulin. Przegl Lek 1974; 30: 902–9
   Google Scholar
• Harris V, Falooma G R, Unger R H. Glucagon. Methods of hormone radioimmunoassay.2nd ed., B M Jaffe, Behrman. Academic Press, New York 1979; 643
   Google Scholar
• Penman E, Wass J AH, Lund A. Development and validation of the specific radioimmunoassay for somatostatin in human plasma. Ann Clin Biochem 1979; 16: 15–25
   PubMed Web of Science ®Google Scholar
• Hüdebrand P, Ensinck J W, Ketterer S. Effect of cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. J Clin Endocrinol Metab 1991; 72: 1123–9
   PubMedGoogle Scholar
• Liddle R A, Gertz B J, Kanayama S. Regulation of pancreatic endocrine function by cholecystokinin, studies with MK-329, a non peptide cholecystokinin receptor antagonist. J Clin Endocrin Metab 1990; 70: 1311–8
   Google Scholar
• Rushakoff R J, Goldfine I D C, Carter J D, Liddle R A. The physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. J Clin Endocrinol Metab 1987; 65: 395–401
   PubMed Web of Science ®Google Scholar
• Fred M, Schwizer W, Beglinger C, Keller V, Jansen J B, Lamers C B. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonists loxiglumide. Diabetologia 1991; 34: 721–6
   PubMedGoogle Scholar
• Ahren B, Pettersson M, Uvnas-Moberg K, Gutniak M, Efendic S. Effects of cholecystokinin CCK-8, CCK 33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic secretion in man. Diabetes Res Clin Pract 1991; 13: 153–62
   PubMed Web of Science ®Google Scholar
• Friend M, Mayer E A, Bloom S R, Taylor I L, Mayer J H. GIP and insulin release in relation to gastric emptying of a mixed meal in man. Regul Pept 1989; 26: 305–12
   PubMedGoogle Scholar